These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33909465)

  • 21. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
    Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
    Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
    Abe H; Mori N; Tsuchiya K; Schacht DV; Pineda FD; Jiang Y; Karczmar GS
    AJR Am J Roentgenol; 2016 Nov; 207(5):1159-1166. PubMed ID: 27532897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of ultrafast MRI evaluation for predicting histologic upgrade of ductal carcinoma in situ.
    Heo S; Park AY; Jung HK; Ko KH; Kim Y; Koh J
    Eur J Radiol; 2021 Mar; 136():109519. PubMed ID: 33429208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
    Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
    Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
    Mori N; Sheth D; Abe H
    AJR Am J Roentgenol; 2020 Aug; 215(2):511-518. PubMed ID: 32452698
    [No Abstract]   [Full Text] [Related]  

  • 26. Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?
    Kataoka M; Honda M; Ohashi A; Yamaguchi K; Mori N; Goto M; Fujioka T; Mori M; Kato Y; Satake H; Iima M; Kubota K
    Magn Reson Med Sci; 2022 Mar; 21(1):83-94. PubMed ID: 35228489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins.
    Onishi N; Kataoka M; Kanao S; Sagawa H; Iima M; Nickel MD; Toi M; Togashi K
    J Magn Reson Imaging; 2018 Jan; 47(1):97-104. PubMed ID: 28556576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of temporal regularization and radial undersampling factor on compressed sensing reconstruction in dynamic contrast enhanced MRI of the breast.
    Kim SG; Feng L; Grimm R; Freed M; Block KT; Sodickson DK; Moy L; Otazo R
    J Magn Reson Imaging; 2016 Jan; 43(1):261-9. PubMed ID: 26032976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of an ultrafast breast MRI protocol in the differentiation of benign and malignant breast lesions.
    Ramli Hamid MT; Ab Mumin N; Wong YV; Chan WY; Rozalli FI; Rahmat K
    Clin Radiol; 2023 Jun; 78(6):444-450. PubMed ID: 37029001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis.
    Pineda FD; Medved M; Wang S; Fan X; Schacht DV; Sennett C; Oto A; Newstead GM; Abe H; Karczmar GS
    Acad Radiol; 2016 Sep; 23(9):1137-44. PubMed ID: 27283068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI.
    Ohashi A; Kataoka M; Iima M; Honda M; Ota R; Urushibata Y; Dominik Nickel M; Toi M; Zackrisson S; Nakamoto Y
    Eur Radiol; 2023 Nov; 33(11):8132-8141. PubMed ID: 37286791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality.
    Morrison CK; Henze Bancroft LC; DeMartini WB; Holmes JH; Wang K; Bosca RJ; Korosec FR; Strigel RM
    Invest Radiol; 2017 Apr; 52(4):198-205. PubMed ID: 27898602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
    Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
    Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers.
    Trimboli RM; Codari M; Khouri Chalouhi K; Ioan I; Lo Bue G; Ottini A; Casolino D; Carbonaro LA; Sardanelli F
    Radiol Med; 2018 Feb; 123(2):91-97. PubMed ID: 28948442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maximum slope using ultrafast breast DCE-MRI at 1.5 Tesla: a potential tool for predicting breast lesion aggressiveness.
    Pelissier M; Ambarki K; Salleron J; Henrot P
    Eur Radiol; 2021 Dec; 31(12):9556-9566. PubMed ID: 34117556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer.
    Romeo V; Cavaliere C; Imbriaco M; Verde F; Petretta M; Franzese M; Stanzione A; Cuocolo R; Aiello M; Basso L; Amitrano M; Lauria R; Accurso A; Brunetti A; Salvatore M
    Eur J Radiol; 2020 May; 126():108907. PubMed ID: 32145597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary study of the combination of ultrafast and abbreviated dynamic contrast: Enhanced breast magnetic resonance imaging.
    Jeong SM; Ha SM; Ahn HS; Woo S; Sung JK; Shin HC
    Medicine (Baltimore); 2020 Dec; 99(50):e23415. PubMed ID: 33327267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Dynamic Contrast-Enhanced 3D Magnetic Resonance Imaging of the Breast With Fat/Water Separation and High Spatiotemporal Resolution Using Radial Sampling, Compressed Sensing, and Parallel Imaging.
    Benkert T; Block KT; Heller S; Moccaldi M; Sodickson DK; Kim SG; Moy L
    Invest Radiol; 2017 Oct; 52(10):583-589. PubMed ID: 28398929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.